Wednesday, 11 December 2019

Excelra to develop novel therapeutic hypotheses in Dermatology

20 November 2019 | News

In a drug repurposing collaboration with Japan based Maruho

Image credit- excelra.com

Image credit- excelra.com

Hyderabad based Excelra, a leading global Data and Analytics Company has announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in Dermatology.

Under the agreement, the Drug Repurposing Data Scientists and Therapeutic area experts at Excelra will jointly work with Maruho's research team to discover and develop novel therapeutic hypotheses in Dermatology.

The collaboration also gives Maruho an access to Excelra's proprietary Drug Repurposing Platform (GRIP) which comprises of proprietary Repurposing Database, Repurposing Algorithms, Analytics tools and Visualization engine.

The database within GRIP has been built by amassing chemical data (over 7 million chemical entities), biological data and clinical data (over 200,000 data points) which together contribute to more than 10 million associations among 'drug-disease-target' triads.

Dr. Nandu Gattu, Senior Vice President, Pharma Analytics, Excelra said, "We are excited to work with Maruho's Research team to help augment their dermatology pipeline. Together we aim at unlocking innovative treatments to improve the quality of life of millions of patients worldwide."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account